Quick Answer
Dare Bioscience, Inc. reported Stockholders Equity of $2.84 million for fiscal year 2025.
Dare Bioscience, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $2.84M | +147.3% |
| 2024 | -$6.01M | -19.1% |
| 2023 | -$5.05M | -145.4% |
| 2022 | $11.11M | -71.3% |
| 2021 | $38.75M | +3464.9% |
| 2020 | -$1.15M | -361.3% |
| 2019 | $440.8K | -93.4% |
| 2018 | $6.73M | -49.4% |
| 2017 | $13.29M | +1970.6% |
| 2016 | -$710.6K | -1413.7% |
| 2015 | -$46.9K | -100.1% |
| 2014 | $45.33M | +148.1% |
| 2013 | -$94.30M | -17.8% |
| 2012 | -$80.04M | -37.1% |
| 2011 | -$58.40M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $2.86M | +292.5% | +122.4% |
| June 30, 2025 | -$12.73M | -576.6% | -33.1% |
| March 31, 2025 | -$9.56M | +13.1% | -59.1% |
| December 31, 2024 | -$6.01M | -19.1% | -305.0% |
| September 30, 2024 | -$1.48M | +35.1% | -155.6% |
| June 30, 2024 | $2.67M | +198.2% | +124.3% |
| March 31, 2024 | -$11.00M | -321.2% | -117.9% |
| December 31, 2023 | -$5.05M | -145.4% | -120.5% |
- Dare Bioscience, Inc. showed an increase of +147.3% in Stockholders Equity compared to the prior fiscal year.
- Over the 2011–2025 period, Dare Bioscience, Inc.’s stockholders equity has grown by 104.9% (from -$58.40 million to $2.84 million).
- The most recent figure is from Dare Bioscience, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: